Matches in Wikidata for { <http://www.wikidata.org/entity/Q86124513> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q86124513 description "article scientifique publié en 2014" @default.
- Q86124513 description "artículu científicu espublizáu n'ochobre de 2014" @default.
- Q86124513 description "im Oktober 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q86124513 description "scientific article published on 18 October 2014" @default.
- Q86124513 description "wetenschappelijk artikel" @default.
- Q86124513 description "наукова стаття, опублікована в жовтні 2014" @default.
- Q86124513 name "Isofraxidin protects mice from LPS challenge by inhibiting pro-inflammatory cytokines and alleviating histopathological changes" @default.
- Q86124513 name "Isofraxidin protects mice from LPS challenge by inhibiting pro-inflammatory cytokines and alleviating histopathological changes" @default.
- Q86124513 type Item @default.
- Q86124513 label "Isofraxidin protects mice from LPS challenge by inhibiting pro-inflammatory cytokines and alleviating histopathological changes" @default.
- Q86124513 label "Isofraxidin protects mice from LPS challenge by inhibiting pro-inflammatory cytokines and alleviating histopathological changes" @default.
- Q86124513 prefLabel "Isofraxidin protects mice from LPS challenge by inhibiting pro-inflammatory cytokines and alleviating histopathological changes" @default.
- Q86124513 prefLabel "Isofraxidin protects mice from LPS challenge by inhibiting pro-inflammatory cytokines and alleviating histopathological changes" @default.
- Q86124513 P1433 Q86124513-14C93699-D4B9-4D6E-9523-CB5B0D2A2718 @default.
- Q86124513 P1476 Q86124513-1DDDB1B0-0D3A-4638-B39B-8407BAD16087 @default.
- Q86124513 P2093 Q86124513-4183BED3-FB99-410D-8C02-A94694530A96 @default.
- Q86124513 P2093 Q86124513-5B9C97B8-BEF5-4D34-85D4-21BAB6FC60A5 @default.
- Q86124513 P2093 Q86124513-79EEF0F1-01A1-42BD-A668-895C1DF5654D @default.
- Q86124513 P2093 Q86124513-91DC5300-A92D-40F7-A257-CF876E347EB4 @default.
- Q86124513 P2093 Q86124513-946438BE-D16A-4450-B7C5-4A8052F7F200 @default.
- Q86124513 P2093 Q86124513-C2C8F367-35FA-4C08-A6C9-6B006F432073 @default.
- Q86124513 P2093 Q86124513-D07738FA-5BCB-4B40-9174-FACF0B551970 @default.
- Q86124513 P2093 Q86124513-F9C35A9C-B75D-4268-B28B-5CB7B00487E8 @default.
- Q86124513 P304 Q86124513-C639B632-4FE7-4D61-BBE7-95A37FDE6AD6 @default.
- Q86124513 P31 Q86124513-D503E9E2-C301-484D-A65D-4E19812D2615 @default.
- Q86124513 P356 Q86124513-BD0DDA92-8089-44BD-A0B3-6405B4F288F7 @default.
- Q86124513 P433 Q86124513-AC58821A-8379-4659-8349-D18EB98153B4 @default.
- Q86124513 P478 Q86124513-4A094F60-BB4C-46B0-AB04-5EEB3BC17712 @default.
- Q86124513 P577 Q86124513-0DD9A538-A7A7-40C2-93D0-BB5215514B1A @default.
- Q86124513 P698 Q86124513-AF842215-9C80-42EC-A883-8E911488F0AA @default.
- Q86124513 P356 J.IMBIO.2014.10.007 @default.
- Q86124513 P698 25454811 @default.
- Q86124513 P1433 Q15754985 @default.
- Q86124513 P1476 "Isofraxidin protects mice from LPS challenge by inhibiting pro-inflammatory cytokines and alleviating histopathological changes" @default.
- Q86124513 P2093 "Hailin Zhang" @default.
- Q86124513 P2093 "Huan Yao" @default.
- Q86124513 P2093 "Langchong He" @default.
- Q86124513 P2093 "Ling Liu" @default.
- Q86124513 P2093 "Qingli Mu" @default.
- Q86124513 P2093 "Ting Fan" @default.
- Q86124513 P2093 "Wei Xing" @default.
- Q86124513 P2093 "Weifeng Li" @default.
- Q86124513 P304 "406-413" @default.
- Q86124513 P31 Q13442814 @default.
- Q86124513 P356 "10.1016/J.IMBIO.2014.10.007" @default.
- Q86124513 P433 "3" @default.
- Q86124513 P478 "220" @default.
- Q86124513 P577 "2014-10-18T00:00:00Z" @default.
- Q86124513 P698 "25454811" @default.